A White Paper by Ben Bohannon
For medical device manufacturers operating in global markets, precision is not a preference — it is a regulatory requirement. Every technical document, product label, and patient instruction must be translated with the same exacting standards applied to the device itself. A single mistranslated term in a surgical instrument manual or a non-compliant product label can trigger regulatory action, delay market entry, or — in the worst case — contribute to patient harm.
Yet many global manufacturers continue to treat translation as a procurement line item rather than a quality management function. The result is a fragmented, inconsistency-prone approach to language services that introduces significant compliance, operational, and reputational risk.
This white paper examines the unique language challenges facing ISO-certified medical device manufacturers competing in multilingual global markets. Drawing on Translation Excellence, Inc.’s partnership with Mikron Group — a global leader in high-performance production systems and precision automation — we present a documented case for integrating ISO-certified translation and localization services into the core quality management framework of life sciences and manufacturing organizations.
The strategic conclusion is unambiguous: in regulated industries, language quality is product quality.
Medical device manufacturers face one of the most complex and consequential regulatory environments of any global industry. Compliance frameworks — including the EU Medical Device Regulation (MDR 2017/745), the U.S. FDA’s 21 CFR Part 801, ISO 13485:2016, and the device regulations of markets across APAC and LATAM — mandate precise, accurate, and locally compliant documentation at every stage of the product lifecycle.
These requirements extend directly into the domain of language services. Regulatory bodies demand:
Failure to meet these standards does not result in a footnote in a compliance audit. It can mean product recalls, market withdrawal, import bans, and civil liability.
Many manufacturers approach translation as a documentation task rather than a quality function, outsourcing it to general-purpose translation vendors or, increasingly, relying on Neural Machine Translation (NMT) tools without adequate human oversight.
Each of these approaches introduces specific and measurable risks in the medical device context:
Without a controlled translation memory and terminology management system, the same technical component may be translated differently across product lines, document versions, or language pairs. In regulatory submissions and device labeling, this inconsistency is a compliance defect.
Generic translation vendors may produce linguistically fluent output that is technically inaccurate. Medical device translation requires expertise at the intersection of engineering, life sciences, and regulatory affairs — a specialization that most generalist providers do not possess.
NMT tools excel at speed and volume. In medical device contexts, however, their limitations are significant. NMT systems trained on general-purpose corpora are not equipped to handle the highly specialized terminology of precision manufacturing, medtech, or pharmaceutical production. Without a Human-in-the-Loop (HITL) review process performed by domain-certified linguists, NMT output in this context carries unacceptable error risk.
Technical documentation for medical devices often contains proprietary engineering specifications, trade secrets, and pre-submission regulatory data. Routing this content through unsecured translation platforms exposes manufacturers to intellectual property theft and data privacy violations — particularly under the requirements of GDPR in European markets.
The global medical device market is projected to continue its rapid expansion across EMEA, APAC, and LATAM, driven by aging populations, rising healthcare infrastructure investment, and increasing access to advanced surgical and diagnostic technologies. [Source: insert primary citation from Slator or CSA Research, published within the last 24 months]
For manufacturers like Mikron Group, this growth is an opportunity — but only for those equipped to navigate the regulatory and linguistic requirements of each new market. Every new geography entered represents a new set of language compliance obligations.
The CSA Research body of work on regulated industry translation consistently identifies the life sciences and medical device sectors as among the highest-stakes environments for language quality failures, with error remediation costs that dwarf the investment in preventive quality assurance. [Source: CSA Research — link to primary source published within the last 24 months]
Despite the clear regulatory imperative, a significant portion of language service providers operating in the medical device space lack the specific certifications required to guarantee compliant output. The key standards that should be non-negotiable for manufacturers in this sector are:
ISO 13485:2016
Quality management systems for medical device translation
Ensures translation processes meet the same QMS requirements as device manufacturing
ISO 9001:2015
General quality management systems
Guarantees consistent, documented quality across all language service outputs
ISO 9001:2015
Translation service processes and competency
Verifies that translation workflows, linguist qualifications, and review processes meet international standards
ISO 27001
Checking in / Concierge requests.
Protects sensitive technical and regulatory data throughout the translation process
A vendor without these certifications is not merely a lesser option — in regulated markets, they may represent an active compliance liability.
The complexity of global medical device compliance is compounded by the diversity of local language requirements:
The EU MDR requires documentation in the official language(s) of each member state in which a device is placed on the market — a requirement that may span 24 official EU languages for pan-European product launches.
The operative word in each of these contexts is localization — not merely translation. Linguistic conversion alone is insufficient
when regulatory language, cultural conventions, and local standards all require contextual adaptation.
Translation Excellence, Inc.’s engagement with Mikron Group demonstrates how a fully certified, domain-specialized language services partner can integrate seamlessly into the quality management infrastructure of a global medical device manufacturer. The Translation Excellence Way in this context is built on four strategic pillars.
The principle: Translation for medical devices must be treated as a controlled process, governed by the same quality management discipline as manufacturing itself.
Translation Excellence holds ISO 13485:2016 certification for medical device translations — the definitive quality management standard for this sector. This certification ensures that every translation project for a medical device client is:
For Mikron Group — operating across pharmaceutical, medtech, consumer goods, automotive, and general engineering sectors — this certification provides the assurance that translated materials will withstand scrutiny from regulatory bodies in any target market.
Complementary certifications that reinforce this pillar:
The principle: Complexity in the source document demands expertise — not just fluency — in the target language.
Mikron Group’s product portfolio spans some of the most technically demanding domains in modern manufacturing: high-precision automation systems, complex machining platforms, and cutting tools engineered to tolerances measured in microns. The documentation supporting these products — technical manuals, specifications, maintenance guides, and regulatory submissions — is correspondingly complex.
Translation Excellence’s approach to technical documentation in this context is built on three foundations:
The principle: Intellectual property is as valuable as the device itself. Its protection during the translation process is non-negotiable.
Medical device manufacturers invest enormous resources in the engineering innovations that differentiate their products. Technical documentation submitted for translation frequently contains proprietary specifications, pre-submission regulatory data, and competitively sensitive product development information.
Translation Excellence’s ISO 27001 accreditation provides Mikron Group with verifiable assurance that:
In an era of increasing cyber risk and heightened regulatory scrutiny of data handling practices, ISO 27001 certification is not a differentiator — it is a baseline expectation for any language services partner working with regulated industry clients.
The principle: Market entry requires more than a translated document. It requires communication that is compliant, culturally appropriate, and operationally effective in each target market.
Translation Excellence’s global network of linguists spans the language markets critical to Mikron Group’s international operations, with deep regional expertise across:
Beyond regulatory compliance, cultural localization ensures that Mikron’s communications with international partners, distributors, and end users reflect an understanding of local business norms, communication preferences, and relationship-building conventions. In global supply chain management, this cultural intelligence is a meaningful competitive advantage.
Translation Excellence, Inc.’s engagement with Mikron Group demonstrates how a fully certified, domain-specialized language services partner can integrate seamlessly into the quality management infrastructure of a global medical device manufacturer. The Translation Excellence Way in this context is built on four strategic pillars.
With ISO 13485-certified translation workflows underpinning all regulatory documentation, Mikron’s product submissions and labeling materials consistently meet the language compliance requirements of target market regulators — reducing the risk of submission rejection, label non-conformance, and market entry delays.
By centralizing language services with a single, certified partner capable of managing all language pairs and document types, Mikron eliminated the operational overhead of managing multiple translation vendors across different regions. Streamlined workflows reduced turnaround times and allowed product development and regulatory timelines to proceed without language-related bottlenecks.
Accurate, culturally sensitive communication signals to international partners, distributors, and end users that Mikron operates to the same high standards globally as it does domestically. In markets where regulatory compliance is closely scrutinized, this consistency reinforces Mikron’s reputation as a quality-first organization.
The consequences of translation errors in medical device documentation — product recalls, regulatory sanctions, legal liability — represent risks of a magnitude that dwarfs any investment in preventive language quality assurance. TE’s certified processes function as a risk management tool, systematically reducing the probability of language-driven compliance failures.
ISO 27001-governed data handling procedures ensured that Mikron’s proprietary technical content was protected throughout every stage of the translation process — a critical assurance for a company whose competitive position depends on the precision and confidentiality of its engineering innovations.
Translation Excellence, Inc.’s engagement with Mikron Group demonstrates how a fully certified, domain-specialized language services partner can integrate seamlessly into the quality management infrastructure of a global medical device manufacturer. The Translation Excellence Way in this context is built on four strategic pillars.
Regulatory submission rejection, labeling non-compliance
Market entry delayed 6–18 months; resubmission costs
Included in certified translation workflow
Product recall due to IFU translation error
Recall logistics + regulatory penalties + reputational damage
Prevented through HITL review and domain expertise
IP exposure through unsecured translation platformIP exposure through unsecured translation platform
Legal costs + competitive disadvantage
Mitigated by ISO 27001-certified data handling
Inconsistent terminology across markets
Quality audit findings; remediation across document sets
Prevented through centralized terminology management
Centralized, certified language services reduce the administrative burden of vendor management, eliminate redundant translation work through translation memory leverage, and compress regulatory timelines by delivering compliant documentation on first pass.
Every week shaved from a product’s time-to-market in a new geography represents tangible revenue upside. Language compliance failures that delay market entry carry an opportunity cost that is frequently underestimated in pre-launch planning.
For ISO-certified manufacturers of medical devices and precision production systems, the quality standard does not stop at the factory door. It extends to every document, every label, and every communication that represents the product in the marketplace.
The Mikron Group partnership demonstrates that the right language services partner is not simply a vendor — it is a quality management function. By embedding ISO 13485-certified translation processes, ISO 27001-secured data handling, and culturally competent localization into their global operations, Mikron has built a language infrastructure equal to the precision standards for which the company is known worldwide.
As global regulatory requirements grow more stringent and markets more competitive, the manufacturers who treat language quality as a strategic asset — rather than a documentation afterthought — will hold a measurable advantage in compliance speed, market access, and international brand equity.
In medical device manufacturing, the cost of a mistranslation is never merely linguistic. It is operational, regulatory, and human.
Translation Excellence, Inc. is a full-service Language Service Provider (LSP) holding ISO 13485:2016, ISO 9001:2015, ISO 17100:2015, and ISO 27001 certifications. We specialize in translation, localization, and language training for regulated industries including medical devices, life sciences, pharmaceutical, and precision manufacturing. With a global network of domain-certified linguists and a commitment to HITL quality workflows, TE delivers language services that meet the exacting standards of the world’s most complex industries.
Schedule a Global Readiness Audit with Translation Excellence, Inc. Our certified team will assess your current translation and localization workflows, identify compliance gaps across your target markets, and design a language quality program built to the standards your industry demands.